Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125231821 | 12523182 | 1 | I | 20160516 | 20160702 | 20160702 | PER | US-ASTRAZENECA-2016SE53615 | ASTRAZENECA | 0.00 | F | Y | 113.40000 | KG | 20160702 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125231821 | 12523182 | 1 | PS | BYETTA | EXENATIDE | 1 | Unknown | 250 MCG / 2.4 ML PEN, 10 UG, TWO TIMES A DAY | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 125231821 | 12523182 | 2 | SS | BYETTA | EXENATIDE | 1 | Unknown | 250 MCG / 2.4 ML PEN, 10 UG, TWO TIMES A DAY | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 125231821 | 12523182 | 3 | C | JENTADUETO | LINAGLIPTINMETFORMIN HYDROCHLORIDE | 1 | 0 | 2.5 | MG | BID | |||||||||
| 125231821 | 12523182 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 125231821 | 12523182 | 5 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | 10.0MG UNKNOWN | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125231821 | 12523182 | 3 | Blood glucose decreased |
| 125231821 | 12523182 | 4 | Thyroid disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125231821 | 12523182 | Arrhythmia | |
| 125231821 | 12523182 | Blood glucose increased | |
| 125231821 | 12523182 | Blood pressure increased | |
| 125231821 | 12523182 | Glycosylated haemoglobin increased | |
| 125231821 | 12523182 | Off label use | |
| 125231821 | 12523182 | Product contamination physical | |
| 125231821 | 12523182 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125231821 | 12523182 | 1 | 2012 | 0 | ||
| 125231821 | 12523182 | 2 | 201602 | 0 | ||
| 125231821 | 12523182 | 4 | 2006 | 0 | ||
| 125231821 | 12523182 | 5 | 2015 | 0 |